Provided by Tiger Fintech (Singapore) Pte. Ltd.

Companhia Brasileira De Distribuicao

0.4450
+0.0000
Volume:- -
Turnover:- -
Market Cap:218.06M
PE:-0.26
High:0.4450
Open:0.4450
Low:0.4450
Close:0.4450
Loading ...

Metrics, Billbergia to develop $3b twin tower project in Sydney CBD

The Australian Financial Review
·
16 Jan

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

Business Wire
·
15 Jan

Press Release: Franklin Street Properties Corp. Declares Quarterly Dividend

Dow Jones
·
11 Jan

Cronos Group Inc. (CRON): Among the Best CBD Stocks to Invest In Right Now

Insider Monkey
·
10 Jan

SNDL Inc. (SNDL): Among the Best CBD Stocks to Invest In Right Now

Insider Monkey
·
10 Jan

Why The Scotts Miracle-Gro Company (SMG) Is the Best CBD Stock to Invest In Right Now

Insider Monkey
·
09 Jan

Is Tilray Brands, Inc. (TLRY) the Best CBD Stock to Invest In Right Now?

Insider Monkey
·
09 Jan

Is Canopy Growth (CGC) Among the Best CBD Stocks to Invest In Right Now?

Insider Monkey
·
09 Jan

Why Is Village Farms International (VFF) One of the Best CBD Stocks to Invest In Right Now?

Insider Monkey
·
09 Jan

Why Is Aurora Cannabis (ACB) One of the Best CBD Stocks to Invest In Right Now?

Insider Monkey
·
09 Jan

Commentary: What Singapore’s CBD peregrine falcons can teach us about conservation

CNA
·
07 Jan

Supply crunch seen for Singapore Core CBD Grade A office market

businesstimes
·
29 Dec 2024

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Business Wire
·
19 Dec 2024

Bitcoin Maintains $96,000 Support Amid $23 Billion Accumulation Wave

BE[IN]CRYPTO
·
10 Dec 2024

Cannasouth Ltd - Confirms That Nz Regco Has Accepted Application to Delist From NZX Main Board

THOMSON REUTERS
·
10 Dec 2024

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Business Wire
·
09 Dec 2024